More reads

• For Joe Biden, a final chance at becoming a cancer-focused commander-in-chief. (STAT)
• How biotech went from “no way” to payday in the cannabis business. (MIT Tech Review)
• Opioid maker Insys plunges on warning of possible bankruptcy. (Bloomberg)
• Grail, the liquid biopsy startup, picks an approach for its cancer test. (STAT)
• Correction: In Friday's Readout we misstated the effect of a proposed SEC policy. It would allow certain companies to avoid independent audits of their financial controls, not of their financial results.